| Y/e 31 Mar( In .Cr) | Mar-2025 | Mar-2024 | Mar-2023 | Mar-2022 |
|---|---|---|---|---|
Equity Capital | 46.05 | 30.51 | 9.82 | 8.74 |
Preference Capital | 0 | 0 | 0 | 0 |
Reserves | 661.92 | 137.61 | 29.11 | 24.95 |
Net Worth | 707.97 | 168.12 | 38.93 | 33.69 |
Minority Interest | ||||
Debt | 102.74 | 100.69 | 60.66 | 14.75 |
Deferred Tax Liability Net | 0.75 | 0.22 | 0 | 0 |
Total Liabilities | 811.46 | 269.03 | 99.59 | 48.44 |
Fixed Assets | 88.6 | 42.56 | 19.1 | 4.76 |
Intangible Assets | ||||
Investments | 104.38 | 81.58 | 8.23 | 11.69 |
Deferred Tax Asset Net | 1.05 | 0.43 | 0.18 | 0.45 |
Networking Capital | 257.71 | 134.01 | 71.98 | 30.13 |
Inventories | 8.66 | 4.52 | 3.12 | 2.98 |
Inventory Days | ||||
Sundry Debtors | 25.69 | 22.01 | 15.73 | 8.37 |
Debtor Days | ||||
Other Current Assets | 246.74 | 124.53 | 65.27 | 25.5 |
Sundry Creditors | -16.42 | -12.87 | -4.39 | -6.05 |
Creditor Days | ||||
Other Current Liabilities | -6.96 | -4.18 | -7.75 | -0.67 |
Cash | 359.72 | 10.45 | 0.09 | 1.41 |
Total Assets | 811.46 | 269.03 | 99.58 | 48.44 |
Senores Pharmaceuticals intends to fund the acquisition through proceeds from its IPO, which raised ₹5.82 billion in December.
Senores Pharmaceuticals shares closed 6% below their listing price, although they are still up 43% from the IPO price.
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
